Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
8.91
+0.17 (1.95%)
At close: Sep 26, 2025, 4:00 PM EDT
8.91
0.00 (0.00%)
After-hours: Sep 26, 2025, 4:10 PM EDT
Emergent BioSolutions Employees
Emergent BioSolutions had 900 employees as of December 31, 2024. The number of employees decreased by 700 or -43.75% compared to the previous year.
Employees
900
Change (1Y)
-700
Growth (1Y)
-43.75%
Revenue / Employee
$946,222
Profits / Employee
$155,000
Market Cap
475.36M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 900 | -700 | -43.75% |
Dec 31, 2023 | 1,600 | -900 | -36.00% |
Dec 31, 2022 | 2,500 | 84 | 3.48% |
Dec 31, 2021 | 2,416 | 216 | 9.82% |
Dec 31, 2020 | 2,200 | 366 | 19.96% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
EBS News
- 2 days ago - Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone - GlobeNewsWire
- 7 days ago - Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner - GlobeNewsWire
- 11 days ago - Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain - GlobeNewsWire
- 17 days ago - Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Preparedness - GlobeNewsWire
- 24 days ago - Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use - GlobeNewsWire
- 4 weeks ago - Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day - GlobeNewsWire
- 4 weeks ago - Emergent BioSolutions to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day™ - GlobeNewsWire